MétaCan
Menu
Back to cohort
Record W7070457757

Optimization and Mechanistic Exploration of Intravenous Human Immunoglobulin G for Treatment of Traumatic Cervical Spinal Cord Injury

2021· dissertation· W7070457757 on OpenAlexfundno aff

Bibliographic record

VenueTSpace · 2021
Typedissertation
Language
FieldBiochemistry, Genetics and Molecular Biology
TopicGenetics, Bioinformatics, and Biomedical Research
Canadian institutionsnot available
FundersUniversity of TorontoStem Cell Network
KeywordsSpinal cord injuryImmune systemImmunosuppressionInflammationNeurovascular bundleAntibodyDosingMechanism (biology)
DOInot available

Abstract

fetched live from OpenAlex

Spinal cord injury (SCI) causes devastating functional impairments and socioeconomic consequences for patients and family members. The pathology is characterized by an initial physical trauma which is amplified by secondary injury mechanisms including vascular and inflammatory processes. The blood-spinal cord-barrier (BSCB) consists of pericytes, astrocytes and endothelial cells, which collectively form the neurovascular unit (NVU). After SCI, a compromised BSCB enables peripheral immune cells to enter the injury site. This inflammatory response has polarizing effects. While immune cells are beneficial by secreting growth factors that promote regeneration after SCI, they also propagate injury when sterilizing the injured area. Thus, immunomodulation is becoming the preferred clinical intervention to immunosuppression when resolving neuroinflammation. Approved by regulatory authorities as an immunomodulatory therapy, intravenous human immunoglobulin G (IVIg) may be suitable for treating SCI. While prior work has suggested a possible beneficial role for IVIg in the treatment of acute SCI, the clinical translation of this work has been hindered by critical knowledge gaps including uncertainty around mechanism of action, the optimal dosing and the post-injury therapeutic window. Therefore, this thesis aims to use a clinically relevant rat model of SCI to provide insights into the optimal dose, therapeutic time window and mechanism of action. My work determined that the optimal therapeutic dose of IVIg is 2g/kg and that beneficial effects were maintained when administered up to 4 hours post-SCI. My work showed that IVIg binds to BSCB cells, strengthening the BSCB and reducing neutrophil infiltration at 24 hours post-SCI. This is associated with long-term motor and sensory recovery and spinal cord tissue preservation. Immunomodulatory effects mediated by IVIg (2g/kg) might be explained in two-fold, where human immunoglobulin G (hIgG) antagonizes neutrophil infiltration into the spinal cord by co-localizing with endothelial cell ligands that mediate neutrophil extravasation. Moreover, IVIg traffics neutrophils to the spleen by increasing expression of neutrophil chemoattractants in spleen and sera. In conclusion, this work demonstrates that IVIg might be a suitable treatment for SCI with potential for clinical translation. IVIg (2g/kg) enhances short-term and long-term benefits after SCI by modulating local and systemic neuroinflammatory cascades.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.172
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.379
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueTSpaceSame topicGenetics, Bioinformatics, and Biomedical ResearchFrench-language works237,207